Latest News

New research suggests that photon-counting CT may provide critical insight into a diagnostic dilemma that has challenged radiologists for decades.

For patients with advanced melanoma, the melanin-targeted PET radiotracer (¹⁸F)DMPY2 offered superior detection of metastatic foci in the brain and liver in comparison to (¹⁸F)FDG, according to preliminary comparative research presented at the recent SNMMI conference.

In a recent interview, Mary L. Bouxsein, PhD, discussed challenges with access to dual-energy X-ray absorptiometry (DEXA) screening for osteoporosis, the emergence of biomechanical CT (BCT) and the potential impact of national Medicare coverage of BCT for bone mass measurement.

Catch up on the latest imaging research from the recent SNMMI conference.

For pancreatic cancers less than or equal to 20 mm, a deep learning model offered a nearly 45 percent higher sensitivity rate with non-contrast CT in comparison to unassisted radiologist interpretation.

Noting that frustration over slow implementation of technological advances may be contributing to mounting radiologist frustration and subsequent burnout, this author offers key principles for integrating technological solutions into radiology workflows.

In the latest episode of the Molecular Imaging in Focus series, Michael Hofman, MBBS, FRACP, discussed the potential of an emerging PET radiotracer for DVT detection spotlighted in SNMMI’s “Image of the Year,” a new advance in total body PET/CT and other highlights from the SNMMI conference.

While use of an AI software demonstrated significantly higher accuracy in evaluating BI-RADS 2 presentations and no significant difference with radiologists in BI-RADS 4 assessments of breast ultrasound in a sub-analysis, researchers noted the exclusion of galactoceles, fluid collections and skin lesions that are commonly found in pregnant and lactating women.

In a recent interview, new SNMMI president Heather Jacene, MD, discussed key goals for bolstering workforce development in nuclear medicine, improving infrastructure equity and optimizing emerging advances to facilitate precision treatments in oncology.

Indicated for the detection and visualization of abnormal vascularity in the central nervous system (CNS) and non-CNS body regions, gadoquatrane provides 60 percent less gadolinium dosing in comparison to other macrocyclic gadolinium (Gd)-based contrast agents (mGBCAs).

Catch up on the top radiology content of the past week.

In a recent interview, Nina Kottler, MD, discussed the challenges with traditional radiology reporting, its impact on cognitive load and the recently launched AI-enabled platform Mosaic Reporting.

New research suggests the silent accumulated social costs of remote work are outweighing the benefits of increased flexibility and autonomy.